Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. 1999

U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
Department of Cardiovascular Surgery, University of Cologne, Germany. uwe.mehlhorn@medizin.uni-koeln.de

The authors' recent experimental work has demonstrated that myocardial protection using continuous coronary perfusion with warm beta-blocker-enriched blood avoids myocardial ischaemia and minimizes myocardial oedema formation, thus completely preserving left ventricle function. The purpose of this clinical study was to compare this alternative technique in terms of structural and functional myocardial protection with the routinely used crystalloid Bretschneider cardioplegia. Sixty coronary artery surgery patients were randomized to receive either crystalloid cardioplegia or continuous coronary perfusion with warm blood enriched with the ultra-short acting beta-blocker esmolol. Cardiac function was evaluated using transoesophageal echocardiography (fractional area of contraction) and cardiac metabolism using arterial-coronary sinus lactate concentration difference (a - csD(LAC)). From left ventricular biopsies, the authors determined myocardial oedema, heat-shock-protein-70, intercellular-adhesion-molecule and actin pattern. Patients with crystalloid cardioplegia received 3.6 +/- 0.8 grafts during 64 +/- 20 min cross-clamp time (beta-blocker: 3.5 +/- 0.9 grafts during 68 +/- 22 min; NS). Following cross-clamp removal crystalloid cardioplegia hearts released significant lactate amounts (a- csD(LAC)) - 1.0 +/- 0.6 versus - 0.1 +/- 0.2 mmol/litre in beta-blocker hearts; P < 0.05). In crystalloid cardioplegia hearts, myocardial water content increased from 82.1 +/- 2.1% pre-cardiopulmonary bypass to 83.2 +/- 1.7% at the end of cardiopulmonary bypass (P < 0.05); in beta-blocker hearts myocardial water content remained unchanged (pre-cardiopulmonary bypass: 82.3 +/- 1.9%; end of cardiopulmonary bypass: 82.4 +/- 1.7%; NS). At the end of cardiopulmonary bypass, left ventricular biopsies of beta-blocker hearts showed less structural damage as determined by heat shock protein-70, intercellular adhesion molecule-I and deranged actin cross-striation pattern as compared with crystalloid cardioplegia hearts (P < 0.05). The post-cardiopulmonary bypass fractional area of contraction was similar in both groups (beta-blocker: 65 +/- 14%; crystalloid cardioplegia: 62 +/- 16%); however, beta-blocker patients required less inotropic stimulation (dopamine: beta-blocker: 2.9 +/- 2.5 versus crystalloid cardioplegia: 5.0 +/- 2.3 microg/kg per min; P < 0.05). The data suggest that continuous coronary perfusion with warm esmolol-enriched blood results in better myocardial protection compared with crystalloid cardioplegia. It is concluded that the concept of beta-blocker-induced cardiac surgical conditions may be a useful alternative for myocardial protection during coronary artery surgery.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002314 Cardioplegic Solutions Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. Cardioplegic Solution,Solution, Cardioplegic,Solutions, Cardioplegic
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D005260 Female Females
D006324 Heart Arrest, Induced A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate). Cardiac Arrest, Induced,Cardioplegia,Induced Cardiac Arrest,Induced Heart Arrest,Cardioplegias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
April 1998, The Annals of thoracic surgery,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
December 1979, New York state journal of medicine,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
September 2010, Basic research in cardiology,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
April 1982, The Annals of thoracic surgery,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
January 1984, Scandinavian journal of thoracic and cardiovascular surgery,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
October 1979, Acta anaesthesiologica Scandinavica,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
September 1998, The Thoracic and cardiovascular surgeon,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
January 2000, Indian heart journal,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
January 1979, Anaesthesia,
U Mehlhorn, and H Sauer, and F Kuhn-Régnier, and M Südkamp, and S Dhein, and F Eberhardt, and S Grond, and M Horst, and K Hekmat, and H J Geissler, and R D Warters, and S J Allen, and E Rainer de Vivie
January 2001, The heart surgery forum,
Copied contents to your clipboard!